Cytodyn of New Mexico, Inc. v. Amerimmune Pharmaceuticals, Inc.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• “[A] prima facie claim for misappropriation of trade secrets ‘requires the plaintiff to demonstrate [that it] owned [the] trade secret’”
• “Under the UTSA, a prima facie 11 claim for misappropriation of trade secrets ‘requires the plaintiff to demonstrate: (1) the plaintiff 12 owned a trade secret, (2) the defendant acquired, disclosed, or used the plaintiff’s trade secret 13 through improper means, and (3
• “Under the UTSA, a prima 3 facie claim for misappropriation of trade secrets ‘requires the plaintiff to demonstrate: (1) the 4 plaintiff owned a trade secret, (2) the defendant acquired, disclosed, or used the plaintiff’s trade 5 secret through improper means, and (3
• same for trade secret misappropriation

Source: CourtListener parenthetical corpus (CC0).